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A comparison of copper and acid site zeolites for the production 
of nitric oxide for biomedical applications  
Samantha E. Russell,a Juan María González Carballo,b Claudia Orellana-Tavra,c David Fairen-
Jimenezc and Russell E. Morrisa 
Copper-exchanged and acidic zeolites are shown to produce nitric oxide (NO) from a nitrite source in biologically active 
(nanomolar) concentrations. Four zeolites were studied; mordenite, ferrierite, ZSM-5 and SSZ-13, which had varying pore 
size, channel systems and Si/Al ratios. ZSM-5 and SSZ-13 produced the highest amounts of NO in both the copper and acid 
form. The high activity and regeneration of the copper active sites makes them good candidates for long-term NO 
production. Initial cytotoxicity tests have shown at least one of the copper zeolites (Cu-SSZ-13) to be biocompatible, 
highlighting the potential usage within biomedical applications.  
Introduction 
The discussion of zeolites and nitric oxide (NO) most 
frequently relates to de-NOx catalysis, where zeolites work to 
reduce NO emissions at high temperatures in car exhausts.1–3 
Here we discuss an interesting manipulation of this well-
known process with zeolites that can produce NO at room 
temperatures. NO is an extremely important molecule within 
the body, with the discovery of its signalling properties 
awarded a Nobel Prize in 1998. Materials that deliver this 
molecule therefore have potential to be used in medical 
applications due to the anti-thrombotic and vasodilating 
properties of NO.4–6  
Up until now, the vast majority of NO delivery mechanisms 
have involved NO stored inside the materials and delivered 
when required. Porous materials, such as MOFs and zeolites, 
have been used for NO storage and release, where upon 
exposure to water the NO molecules are displaced, delivering 
the gas.7,8 Other methods have used NO donor molecules, 
where compounds such as sodium nitroprusside (SNP) and 
glyceryl trinitrate (GTN), decompose within the body to release 
NO.9 Both methods have shown to be very effective for a 
range of ailments, such as wound-healing,10 rapid blood 
pressure lowering11 and pain relief for angina.12 The obvious 
disadvantage of stored NO is that the reservoir will eventually 
run out at some point, making stored NO suitable only for 
relatively short-term applications. However, there are several 
examples of the chemical production of NO. Perhaps the most 
important of these is the use of the nitrite ion as a substrate 
from which NO is produced. This can be done in two ways, 
either by the reaction of nitrite with an acid13 or by interaction 
of nitrite with copper ions.14 The acidified nitrite route is one 
that has received much attention, but one potential drawback 
is that this chemical route has been shown to produce severe 
inflammatory response in certain situations.15 This response 
has been ascribed to side products of the reaction. Copper-
mediated production of NO has also been studied as a 
potential source of biomedically active NO,16 with copper ions 
being accommodated within polymers17 and porous materials, 
including examples of metal-organic frameworks,18 
mesoporous materials19 and a copper zeolite.20 The significant 
advantage of this type of approach over stored NO approaches 
is that there is the possibility of replenishing the source of the 
nitrite substrate for as long as the activity of the material 
remains potent enough. There is also the advantage that 
materials that store NO may need to be stored under special 
conditions (e.g. away from moisture). Such requirements 
should not be necessary for acid- or copper-mediated 
production of NO. Here we compare four well-known zeolite 
materials (mordenite, ferrierite, ZSM-5 and SSZ-13) in the acid 
and copper-exchanged form for the production of nitric oxide 
from  biologically available sources. Cysteine and nitrite are 
both abundant within blood plasma, with concentrations of 
250 µmol/L and 4.2 µmol/L, respectively.21,22 While the nitrite 
acts as a substrate for both active sites, the cysteine works as a 
sacrificial reductant to generate the active copper site, Figure 
1. All four zeolites have been heavily studied for their deNOx 
potential, and Cu-SSZ-13 has, in particular, been a recent 
addition to commercially-used zeolites in automotive deNOx 
applications.  This material has excellent properties for the 
destruction of NO, but it should also have good properties for 
NO production – small pores to aid selectivity towards small 
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products like NO (and so limit any possible side products), 
good hydrothermal stability etc. Our hypothesis was therefore 
that SSZ-13 should be an excellent material to produce NO 
from nitrite.   
Experimental 
Zeolite Syntheses 
Ferrierite was synthesised according to the standard literature 
for zeolite synthesis23 with a batch composition of 1.85 Na2O : 
Al2O3 : 15.2 SiO2 : 592 H2O : 19.7 ethylenediamine. The copper-
exchanged mordenite sample was synthesised from 
literature24 with a batch composition of 12 Na2O : 2Al2O3 : 100 
SiO2 : 500 H2O. The acidic mordenite sample was also 
synthesised from literature23 with a batch composition of 6 
Na2O : Al2O3 : 30 SiO2 : 780 H2O. NH4-ZSM-5 was obtained from 
Zeolyst (CBV 3024E) and H-SSZ-13 was obtained from Chevron. 
Full synthesis details can be found in the SI. The purity of the 
synthesised samples were determined by powder X-ray 
diffraction (PXRD), and their morphologies studied by scanning 
electron microscopy (SEM), Figure S1 and S2 respectively. 
PXRD samples were run on a PANalytical Empyrean, Cu X-ray 
tube, primary beam monochromator (CuKa1), 15-position 
sample changer with an X'celerator RTMS detector.  SEM 
samples were gold coated by a Quorum Q150R ES coating 
system and images recorded with a Jeol JSM-5600 Scanning 
Electron Microscope with an Oxford Inca EDX system. 
 
Active Site Formation 
The Brønsted acid sites of each zeolite were formed by ion-
exchanging the zeolites with ammonium cations using 
ammonium chloride solution (0.3 M), followed by calcination 
at high temperature. Ammonium chloride solution and zeolite 
(10 mL/50 mg) were stirred overnight at room temperature. 
The solid was then filtered and washed. This exchange 
procedure was repeated three times. The ion-exchanged 
sample was then calcined at 575 °C for 6 hours at a rate of 1.5 
°C /min to release ammonia, forming the acid site. The number 
and strength of the sites were studied using ammonia 
temperature programmed desorption (NH3-TPD). 
The copper sites were formed by copper ion-exchange. The 
zeolites were stirred with copper nitrate solution (0.3 M) for 
up to 24 hours at 90 °C using 10 mL/50 mg zeolite. The 
exchanged sample was then filtered and washed with water. 
The exchange efficiency was studied using energy dispersive X-
ray spectroscopy (EDX), with a target Cu/Al ratio of 
approximately 0.5. It is assumed that the nitrate anions form 
sodium nitrate with the sodium cations that are exchanged out 
of the zeolite pores. The sodium nitrate will remain in solution 
and be removed upon filtration. 
 
Ammonia Temperature Programmed Desorption (NH3-TPD) 
The strength and number of acid sites in the acid zeolites were 
studied by NH3-TPD using a Micromeritics AutoChem 2950 
coupled to a Balzers Thermostar quadrupole Mass 
Spectrometer. 80 mg of the zeolite samples were loaded into 
the U-shaped quartz reactor. Firstly, each sample was 
dehydrated following a two stage process by heating at 120 °C 
for 30 minutes, and then at 500 °C for 20 minutes under Ar. 
The system was then cooled down to 100 °C and the flow 
switched to ammonia (15 volume % NH3 in He) flow for 60 
minutes. The reactor was then evacuated with argon gas for 60 
minutes to remove any free, unbound ammonia molecules. 
The bound ammonia was finally desorbed from the zeolites 
with a gradual temperature increase from 100 °C to 500 °C 
with a heating ramp of 10 °C/min. Ammonia desorption was 
monitored by mass spectrometry (m/z 17). 
 
NO Production Testing 
The activities of the zeolites were studied by the conversion of 
sodium nitrite to nitric oxide. 5 mg of zeolite and 2.6 mL of 
distilled water were stirred in a capped vial, with a nitrogen 
gas inlet. The NO produced after an injection of sodium nitrite 
was carried to a Sievers 280i Nitric Oxide Analyser (NOA) via an 
outlet needle. The NOA monitored the concentration of NO 
produced throughout the reaction, allowing determination of 
total NO production. All runs were recorded in triplicate.  
Cysteine hydrochloride (0.05 M, 25 µL) was injected 5 minutes 
into the run, followed by a sodium nitrite injection (0.05 M, 5 
µL) 15 minutes into the run. The acid sites did not require 
activation; therefore only sodium nitrite (0.05 M, 250 µL) was 
required and injected 5 minutes into the run.  
 
Copper Cytotoxicity Testing 
The cytotoxicity of the copper zeolites was determined by 
measuring the cellular metabolic activity using an MTS 
reduction assay. The viability of HeLa cells was studied after 24 
hour incubation with ranging concentrations of copper zeolites 
(0, 0.25, 0.50 and 1.00 mg/mL). The viability values for the 
differing concentrations were normalised by the control value 
of untreated cells (cells incubated only with growth media and 
no zeolite). Full protocol described in SI.  
Cu2+ 
Cu+ 
RS-H 
RS-SR 
NO 
NO2
- 
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Results and Discussion 
Zeolite Characterisation 
EDX was used to determine the final Si/Al of the zeolites. 
Different synthesis batches of mordenite were used for the 
copper and acid sites. Mordenite with a Si/Al ratio of 6.00 was 
used for the copper sites and a Si/Al of 7.76 was used for the 
acid sites. All other zeolites used the same batch for both the 
acid and copper sites. Ferrierite had a Si/Al of 6.05, ZSM-5 
15.17 and SSZ-13 15.17 also. 
 
Ammonia Temperature Programmed Desorption (NH3-TPD) 
Figure 2 shows the m/z 17 profiles monitored during the NH3-
TPD. The profiles are governed by two desorption peaks, one 
in the region of 100 – 275 °C which corresponds to weakly 
bound NH3 and the second from 275 – 500 °C which 
corresponds to strongly bound NH3. The second desorption 
peak correlates to the acid site strength and the number of 
acid sites. The lowest desorption temperature, and therefore 
weakest acid, is H-ZSM-5 which peaks around 400 °C. The 
greatest desorption temperature, and therefore strongest 
acid, is H-MOR which peaks around 500 °C. The desorption 
profiles of MOR and FER reveals that temperatures above 500 
°C are necessary to fully desorb NH3. This highlights the higher 
acidity of these materials compared to ZSM-5 and SSZ-13. Due 
to this, attempts to quantify the number of acid sites by 
integrating the area under the profile may lead to incorrect 
data. Therefore, the peak heights suggest currently that H-
ZSM-5 has the lowest number of acid sites and H-SSZ-13 has 
the greatest. Overall we observe acid site strength as 
MOR>SSZ-13>FER>ZSM-5 and acid site number as SSZ-
13>MOR>FER>ZSM-5.  
 
Acid Sites 
The average total NO produced by the four acid site zeolites 
from the triplicate runs is shown in Figure 3a. 
H-SSZ-13 and H-ZSM-5 produce the highest total amounts of 
NO, producing 337 nmols and 326 nmols respectively. Their 
rates of production, however, are quite different; this can be 
seen by the gradients of the lines in the first couple of hours. 
H-MOR produces an average of 241 nmols of NO per run 
making it the next highest production. H-FER has the lowest 
average production with 187 nmols of NO per run.  Similar to 
the previously discussed difference in rate of production with 
H-ZSM-5 and H-SSZ-13, the initial rate of NO production for H-
FER is higher than that of H-MOR. This may due to pore size or 
particle size. There was a variation in the length of time that 
the zeolites produced NO, ranging from around 5 to 8 hours. 
The general trend of the acid site zeolites was a relatively low 
initial NO concentration with a  long production time. 
Interestingly, there is little obvious correlation between the 
NH3-TPD results and the amount of NO produced. H-SSZ-13 
had the greatest number of acid sites and the second highest 
strength, therefore the greatest NO production was expected. 
H-ZSM-5 however, had an extremely similar NO production to 
H-SSZ-13, yet has the weakest and lowest number of acid sites, 
while H-MOR was the strongest acid sites, yet had the third 
lowest production. This suggests that the accessibility of the 
active sites may be a limitation for mordenite and ferrierite. 
This would explain why the small pores and 3D channel 
systems of SSZ-13 and ZSM-5 may favour interaction between 
the active sites and the nitrite over the larger pored and lower 
channel systems of mordenite and ferrierite.   
 
Copper Sites 
EDX data confirmed that all zeolites had been exchanged to 
the optimum level with a Cu/Al ratio of approximately 0.5, 
data shown in Tables S1 – S4. The average total NO produced 
by the four copper site zeolites from the triplicate runs is 
shown in Figure 3b.  
The results show Cu-SSZ-13 to have the highest NO production 
with around 270 nmols of NO produced over a period of 
roughly 1 hour. The second highest production was from Cu-
ZSM-5 which produced around 267 nmol of NO and took 
around 1.5 hours for total production. Cu-MOR had the third 
highest production of NO with around 130 nmols produced. 
This production was considerably longer, lasting around 6 
hours, at least 2 hours longer than any other copper zeolite 
studied. Cu-FER had a total NO production of around 80 nmols 
produced over a period of around 4 hours. 
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The fact that mordenite and ferrierite have higher aluminium 
contents, and therefore higher copper content, and also larger 
pores, but still a lower and slower rate of nitrite conversion, 
suggest the channel system has a great impact on the 
reactivity. The lower channel systems of mordenite and 
ferrierite (1D and 2D respectively) indicate that active site 
accessibility may be limiting the zeolite activity. The small 
pore, high channel systems (3D) of SSZ-13 and ZSM-5 may 
favour the interaction of the nitrite with the active sites, as 
previously observed with the acid sites. 
 
Further studies of the active site location, both before and 
after the substrate injection, would aid in understanding the 
difference in activity observed by the four zeolites. Previous 
work has suggested that the presence and stability of active 
sites at the channel intersections may explain the difference in 
catalytic activity of ferrierite and ZSM-5.25 This may be similar 
reasoning for why we have observed different activities for the 
four zeolites, with the same activity order observed with both 
the copper and acid active sites. 
Comparing the two sites, it is apparent that the copper sites 
are considerably more active than the acid sites, shown by the 
much lower volume of substrate required to obtain similar 
concentrations of NO. 250 µL of sodium nitrite was used for 
the acid sites compared to the 5 µL used for the copper sites, a 
50 times increase, highlighting the difference in activity.  
 
Copper Cytotoxicity  
The obtained data shows any decrease in cell viability in 
comparison to normalised cell growth. A drop below 80 % of 
cell viability was deemed a negative impact on cell growth and 
therefore cytotoxic. Cu-SSZ-13 was shown to be 
biocompatible, with cell viability not dropping below 100 % 
with any zeolite concentration, Figure 4. Cu-FER and Cu-ZSM-5 
both showed a gradual decrease in cell viability with increasing 
zeolite concentration, therefore the use of these materials in 
biomedical applications would be concentration dependent. 
Finally, Cu-MOR showed a relatively large drop in cell viability 
with any concentration of zeolite, showing a low 
biocompatibility. These results are likely related to the stability 
of the copper zeolites. Cu-SSZ-13 has been reported to have 
long term stability over a range of harsh conditions, with the 
copper addition even increasing stability from the ammonium 
H-SSZ-13 
H-ZSM-5 
H-MOR 
H-FER 
Cu-SSZ-13 
Cu-ZSM-5 
Cu-MOR 
Cu-FER 
 -
 20
 40
 60
 80
 100
 120
V
ia
b
il
it
y
 (
%
)
Copper nitrate concentration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
ZSM-5 Concentration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
Cu-FER Concentration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
SS2-13 Concentration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
Cu-MOR Concentration (mg/mL) Cu-SSZ-13 Concentration (mg/mL) 
 -
 20
 40
 60
 80
 100
 120
V
ia
b
il
it
y
 (
%
)
Copper nitrate c centration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
ZSM-5 Concentration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
Cu-FER Concentration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
SS2-13 Concentration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
Cu-MOR Concentration (mg/mL)
 -
 20
 40
 60
 80
 100
 120
V
ia
b
il
it
y
 (
%
)
Copper nitrate concentration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
ZSM-5 Concentration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
Cu-FER Concentration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
SS2-13 Concentration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
Cu-MOR Concentration (mg/mL)
 -
 20
 40
 60
 80
 100
 120
V
ia
b
il
it
y
 (
%
)
Copper nitrate conce tration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
ZSM-5 Conce tration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
Cu-FER Conce tration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
SS2-13 Conce tration (mg/mL)
0
20
40
60
80
100
120
0 0.25 0.5 1
V
ia
b
il
it
y
 (
%
)
Cu-MOR Conce tration (mg/mL)
Cu-MOR Concentration (mg/mL) 
Cu-ZSM-5 Concentration (mg/mL) Cu-FER Concentration (mg/mL) 
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 5  
Please do not adjust margins 
Please do not adjust margins 
 
exchanged counterpart, therefore highlighting the stability of 
the structure and explaining the biocompatibility.26,27  
 
Active Site Regeneration 
Due to the proposed biomedical applications, it is beneficial 
that the zeolites are able to regenerate the active site to allow 
a catalytic production and therefore a long-term NO 
production. Subsequent nitrite injections were performed with 
both a selected copper and acid site zeolite (Cu-SSZ-13 and H-
SSZ-13) to observe if the initial amount of NO produced was 
obtained from a second substrate injection. An excess of 
cysteine hydrochloride was initially injected into the copper 
sample to ensure it was not a limiting factor for the copper 
sites. 
The results in Figure 5 show that the copper sites of Cu-SSZ-13 
do not lose activity after three nitrite injections, with all 
injections producing between 265 and 282 nmols of NO, as 
shown by the total NO produced. This suggests that the copper 
sites are successfully being regenerated through the use of 
cysteine as a sacrificial reductant. This reveals the high 
potential for long term NO production. The release profile of a 
sample of H-SSZ-13 showed that a second injection of 
substrate produced a considerably lower amount of NO than 
the first, indicating that the acid site has been consumed 
during the first reaction with nitrite. The lack of acid site 
regeneration inhibits their use within long term NO producing 
applications, such as medical device coatings. Although 
currently not suitable for long-term NO production, acid site 
zeolites still have great potential in other areas, such as wound 
healing, where it may be possible to avoid the previously 
discussed inflammatory response observed from other routes. 
Conclusions 
The results reported show the ability of both copper and acid 
site mordenite, ferrierite, ZSM-5 and SSZ-13 to produce nitric 
oxide from sodium nitrite. The best performing zeolites were 
SSZ-13 and ZSM-5, both producing the highest total amounts 
of NO. The zeolite activity appears to be influenced by the 
active site location within the pores, therefore future work 
studying the positions is essential to understand the 
accessibility of the sites. 
The differences between the two active sites are important for 
considering biomedical applications, with activity and 
regeneration two key factors. The current inability of the acid 
sites to be regenerated limits their use in long term NO 
production, but still have potential in other applications. The 
copper sites, however, have shown promising results with 
both high activity and the ability to be regenerated through 
the use of a sacrificial reductant, highlighting their potential in 
biomedical applications. Furthermore, toxicology results show 
the biocompatibility of SSZ-13, indicating great promise for the 
zeolite use within the body. The biologically active 
concentrations of NO produced would be suitable for 
vasodilation and the inhibition of platelet aggregation, 
therefore being an excellent candidate for biomedical 
applications. 
 
 
 
 
 
 
 
Sodium nitrite 
(0.05 M, 5 µL) 
injections 
Sodium nitrite 
(0.05 M, 250 µL) 
injections 
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